´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦41Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ (1ÀÏÂ÷) : 2022-06-24±³À°ÀÏÀÚ : 2022-06-24
±³À°Àå¼Ò : ºÎ»ê ½Ã±×´Ï¿¤ ±×·£µåº¼·ë(4F)
±³À°ÁÖÁ¦ :
´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦41Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ (1ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ
´ã´çÀÚ : Á¤ÀºÇý
¿¬¶ôó : 02-582-8212
À̸ÞÀÏ :
grace@kscvi.org ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
ºÎ»ê±¤¿ª½Ã±³À°½Ã°£ : 13 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 120,000¿ø
ºñ°í - Àü¹®ÀÇ,°³¿øÀÇ,ÀϹÝÀÇ:(ÇöÀåµî·Ï)60,000¿ø - ÀüÀÓÀÇ,Àü°øÀÇ,°£È£»ç,ÀÇ·á±â»ç,ÀÇ´ë»ý,±ºÀÇ°ü,°øÁߺ¸°ÇÀÇ,ÀÓ»óº´¸®»ç,Àǹ«±â·Ï»ç:(ÇöÀåµî·Ï)50,000¿ø - »ê¾÷ü,±âŸ:(ÇöÀåµî·Ï)120,000¿ø - ÇÐȸ Á¤È¸¿ø(Àü³âµµ ȸºñ¿Ï³³ÀÚ): ¹«·á
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-24 Main Arena 10:30~10:40 Anti-platelet Strategies in NSTE ACS(Non-ST Elevation-Acute Coronary Syndrome), Which and When? ±èÇö±¹(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 06-24 Main Arena 10:40~10:50 Timing of Invasive Coronary Angiography in NSTE ACS(Non-ST Elevation-Acute Coronary Syndrome), When and Whom? ÀÌ¿øÀç(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06-24 Main Arena 10:50~11:00 PCI(Percutaneous Coronary Intervention) vs. CABG(Coronary Artery Bypass Grafting), Finding Dividing Lines ÃÖ±âÈ«(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06-24 Main Arena 11:00~11:10 Long-term Management of NSTE ACS(Non-ST Elevation-Acute Coronary Syndrome), Focused on Lifestyle Management ÀÌÁ¾¿µ(¼º±Õ°üÀÇ´ë)
Åä·Ð 06-24 Main Arena 11:10~11:30 Discussion ()
±³À°½Ã°£ 06-24 Symposium Arena 10:30~10:40 I Prefer to the Short-duration Strategy ±èµ¿ºó(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06-24 Symposium Arena 10:40~10:50 I Prefer to the De-escalation Strategy Á¤¿µÈÆ(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 06-24 Symposium Arena 10:50~11:00 I Prefer to the Prasugrel-based De-escalation °Å¼ö(´Ü±¹ÀÇ´ë)
±³À°½Ã°£ 06-24 Symposium Arena 11:00~11:10 I Prefer to the Ticagrelol-based De-escalation ¾È¼º±Õ(¿¬¼¼¿øÁÖÀÇ´ë)
Åä·Ð 06-24 Symposium Arena 11:10~11:30 Discussion ()
±³À°½Ã°£ 06-24 Main Arena 11:40~11:50 ¿µ»óÀ¯ÇüÀÇ ÁßÀç½Ã¼ú¿µ¿ªÀ» ½Ã¼úÀ¯ÇüÀ¸·Î µ¶¸³ÇϱâÀ§ÇÑ Áغñ Á¶´ö±Ô(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06-24 Main Arena 11:50~12:00 ½Ã¼úÀ¯ÇüÀÇ ½Å¼³ÀÇ °¡´É¼º ¹× ¹æÇâ Àü·Î¿ø(Àü·Î¿ø ³»°ú,´ëÇѳ»°úÇÐȸ »ó´ë°¡Ä¡À§¿øÀå)
Åä·Ð 06-24 Main Arena 12:00~12:10 Discussion ()
±³À°½Ã°£ 06-24 Main Arena 12:10~12:20 ½ÉÇ÷°üÁßÀçÀÇ»çÀÇ ÀÔÀå¿¡¼ º» ¹®Á¦Á¡°ú ÇØ°á¹æ¾È ÃÖ±âÈ«(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06-24 Main Arena 12:20~12:30 °æÇèÀû »ç·Ê °íÂû ¹× ÀüÇâÀû ÇØ°á¹æ¾È ±è±¹Èñ(°Ç°º¸Çè½É»çÆò°¡¿ø,¾àÁ¦°ü¸®½Ç ¾àÁ¦±âÁغÎÀå)
Åä·Ð 06-24 Main Arena 12:30~12:40 Discussion ()
±³À°½Ã°£ 06-24 Symposium Arena 11:40~11:52 Pro: Distal Radial Access Should Be the First Access Site for Coronary Intervention À̺À±â(°¿øÀÇ´ë)
±³À°½Ã°£ 06-24 Symposium Arena 11:52~12:04 Cons: Radial Access Is Enough for the First Access Site for Coronary Intervention À¯»ó¿ë(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06-24 Symposium Arena 12:04~12:16 Cons: No, Femoral Access Should Be the First Access Site for Coronary Intervention ±è¼öÁß(°æÈñÀÇ´ë)
Åä·Ð 06-24 Symposium Arena 12:16~12:40 Discussion ()
±³À°½Ã°£ 06-24 Symposium Arena 12:50~13:05 Dual Pathway Inhibition for Antithrombotic Prevention in CV Disease(Cardiovascular Disease) ±Ç¿À¼º(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06-24 Symposium Arena 13:05~13:20 Pre-treatment with Oral P2Y12 Inhibitor in ACS(Acute Coronary Syndrome) Patients: Focused on Clopidogrel ÀÌÁ¾¿µ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06-24 Symposium Arena 13:20~13:35 Which Strategy Is the Best following 1-year DAPT(Dual Antiplatelet Therapy)?: Deep Dive into the HOST-EXAM Trial °ÁöÈÆ(¼¿ïÀÇ´ë)
Åä·Ð 06-24 Symposium Arena 13:35~13:50 Discussion ()
±³À°½Ã°£ 06-24 Main Arena 14:00~14:09 AMI(Acute Myocardial Infarction) ÀÀ±Þ½Ç ³»¿ø½Ã°£ ´ÜÃà, ½Ã¼ú ÈÄ Ä¡·á¼øÀÀµµ, ¾î¶»°Ô °³¼±ÇÒ±î? ¼Á¸(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 06-24 Main Arena 14:09~14:18 Ç÷°üÁßÀç½Ã¼ú °ü·Ã ¹æ»ç¼± ¾ÈÀü°ü¸® ±Ç°í¾È 2022 ±è¼ºÀº(ÇѸ²ÀÇ´ë)
Åä·Ð 06-24 Main Arena 14:18~14:28 Discussion ()
±³À°½Ã°£ 06-24 Main Arena 14:28~14:37 ÀÀ±Þ½Ã¼ú ¿ÂÄÝ´ë±â ¼ö´ç, ¾î¶»°Ô ÇØ¾ß ÇÒ±î? ¹Úâ¹ü(°æÈñÀÇ´ë)
±³À°½Ã°£ 06-24 Main Arena 14:37~14:50 ÀÇ·áºÐÀï, ¾î¶»°Ô ´ëºñÇØ¾ß Çϳª? - ÃֽŠÆÇ·Ê Á᫐ À̵¿ÇÊ(¹ý¹«¹ýÀÎ ÀǼº)
Åä·Ð 06-24 Main Arena 14:50~15:00 Discussion ()
±³À°½Ã°£ 06-24 Symposium Arena 14:00~14:10 Detection and Prediction of Future ACS(Acute Coronary Syndrome)-causing Culprit Lesion by Coronary CT(Computed Tomography) Angiography ÀÌ»óÀº(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 06-24 Symposium Arena 14:10~14:20 Relationship between Clinical Outcomes and Vulnerable Plaque Features Assessed by IVUS(Intravascular Ultrasonography) ¿øÈ£¿¬(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 06-24 Symposium Arena 14:20~14:30 Comparison of Clinical Outcomes between FFR(Fractional Flow Reserve) guided- and IVUS(Intravascular Ultrasonography) Guided PCI(Percutaneous Coronary Intervention) °ÁöÈÆ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06-24 Symposium Arena 14:30~14:40 OCT(Optical Coherence Tomography) Guided Precision PCI(Percutaneous Coronary Intervention): Standard Care from Baseline to Post-stenting À̽·ü(¿ø±¤ÀÇ´ë)
Åä·Ð 06-24 Symposium Arena 14:40~15:00 Discussion ()
±³À°½Ã°£ 06-24 Main Arena 15:10~15:20 TAVR(Transcatheter Aortic Valve Replacement) in Young Age - Pro ¹Ú´ö¿ì(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06-24 Main Arena 15:20~15:30 TAVR(Transcatheter Aortic Valve Replacement) in Young Age - Cons ÀÌ»è(¿¬¼¼ÀÇ´ë)
Åä·Ð 06-24 Main Arena 15:30~15:40 Discussion ()
±³À°½Ã°£ 06-24 Main Arena 15:40~15:50 TAVR(Transcatheter Aortic Valve Replacement) Is Better with Small Annulus ÇÑÁ¤±Ô(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06-24 Main Arena 15:50~16:00 SAVR(Surgical Aortic Valve Replacement) Is Better with Small Annulus À¯Àç¼®(¿ï»êÀÇ´ë)
Åä·Ð 06-24 Main Arena 16:00~16:10 Discussion ()
±³À°½Ã°£ 06-24 Symposium Arena 15:10~15:25 Physiology-guided PCI(Percutaneous Coronary Intervention) Optimization ÀÌÀåÈÆ(°æºÏÀÇ´ë)
±³À°½Ã°£ 06-24 Symposium Arena 15:25~15:40 Nonhyperemic Pressure Ratios: Are They All the Same? ÀåÈ£ÁØ(ºÎõ¼¼Á¾º´¿ø)
±³À°½Ã°£ 06-24 Symposium Arena 15:40~15:55 Coronary Evaluation in Patients with Severe Aortic Stenosis: FFR(Fractional Flow Reserve) vs. iFR(Instantaneous Flow Ratio)? ÀÌÁÖ¸í(¼º±Õ°üÀÇ´ë)
Åä·Ð 06-24 Symposium Arena 15:55~16:10 Discussion ()
±³À°½Ã°£ 06-24 Main Arena 16:20~16:35 ECMO(Extracorporeal Membrane Oxygenation) in AMI(Acute Myocardial Infarction) Complicated by Cardiogenic Shock: Interventional Cardiologist ¾çÁ¤ÈÆ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06-24 Main Arena 16:35~16:50 Beyond ECMO(Extracorporeal Membrane Oxygenation) in AMI(Acute Myocardial Infarcti Complicating Cardiogenic Shock: Cardiac Surgeon Á¤Àç½Â(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06-24 Main Arena 16:50~17:05 Heart Team Approach in Complex Aortic Disease ·ù»ó¿Ï(ÀÌÈÀÇ´ë)
Åä·Ð 06-24 Main Arena 17:05~17:20 Discussion ()
±³À°½Ã°£ 06-24 Symposium Arena 16:20~16:30 When We Meet Invisible or Too Tortous Channels Ȳº´Èñ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06-24 Symposium Arena 16:30~16:40 Difficult Re-entry in rCART(reverse Controlled Antegrade and Retrograde Tracking) À¯Ã¶¿õ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06-24 Symposium Arena 16:40~16:50 Challenges with Wire Externalization ¿øÈ£¿¬(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 06-24 Symposium Arena 16:50~17:00 Problems at Donor Vessel during Intervention ÀÌÁßÈñ(¿¬¼¼¿øÁÖÀÇ´ë)
Åä·Ð 06-24 Symposium Arena 17:00~17:20 Discussion ()
±³À°½Ã°£ 06-24 Main Arena 17:30~17:40 How to Do CTO(Chronic Total Occlusion) in Japan? - Review Japanese Algorithm Yasuhiro Nakano(Kyushu University Hospital. Japan)
±³À°½Ã°£ 06-24 Main Arena 17:40~17:50 How to Do CTO(Chronic Total Occlusion) in Korea? - Korean Style ÀÌÁßÈñ(¿øÁÖ¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06-24 Main Arena 17:50~18:00 Where Are We and What Is the Future Perspective of CTO(Chronic Total Occlusion) in Japan? Atsunori Okamura(Sakurabashi Watanabe Hospital.Japan)
±³À°½Ã°£ 06-24 Main Arena 18:00~18:10 What Is the Evidence of CTO(Chronic Total Occlusion) in Korea? - Literature Review Á¶À翵(¿ø±¤ÀÇ´ë)
Åä·Ð 06-24 Main Arena 18:10~18:30 Discussion ()
±³À°½Ã°£ 06-24 Symposium Arena 17:30~17:45 Concomitant Transcatheter Treatment for Severe Combined Aortic Stenosis and Acute Mitral Regrugitation ÀÌÁøÈ£(¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 06-24 Symposium Arena 17:45~18:00 Percutaneous Transabdominal Approach for the Treatment of Type II Endoleak after Endovascular Repair of Infrarenal Abdominal Aortic Aneurysm ±èÇü¼ö(±¹¹Î°Ç°º¸Çè Àϻ꺴¿ø)
±³À°½Ã°£ 06-24 Symposium Arena 18:00~18:15 A Case of Successful Consecutive Trans-catheter Aortic Valve Implantation, Endovascular Repair after PCI(Percutaneous Coronary Intervention) of Severe Symptomatic Aortic Stenosis, Huge AAA(Abdominal Aortic Aneurysm) and Stable Angina À±¿ø½Ä(ÀüºÏ´ëÇб³º´¿ø)
±³À°½Ã°£ 06-24 Symposium Arena 18:15~18:30 Role of Invasive Hemodyamic Assessment including Exercise Right Heart Catheterization in Patients with HCMP(Hypertrophic Cardiomyopathy) Á¶Çö½Â(¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø)